New agreement will help meet the growing demand for high-performance formulations in polyurethane, coatings, and adhesives production in the United States and Canada
DOWNERS GROVE,...
New platform boosts patient experience and safety, reduces clinician burden, and unlocks operational insight across inpatient mental health hospitals
SYDNEY, Aug. 13, 2025 /PRNewswire/ --...
Pratteln, Switzerland, 13 August, 2025 – Santhera Pharmaceuticals (SIX: SANN) announces the signing of an exclusive agreement with Gen İlaç ve Sağlık Ürünleri San. ve Tic. A.Ş. (GEN) for the distribution and promotion of AGAMREE® (vamorolone) in Türkiye for the treatment of Duchenne muscular dystrophy (DMD) in patients four years of age and older.